VAERS reports by lot

Merck HPV lot 1602281: VAERS reports

30 VAERS reports list lot 1602281 as a Merck HPV vaccine, received between 2019-04-29 and 2022-08-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
30
Reports
10%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2221%
Neurological1716%
Gastrointestinal1716%
Cardiac / Cardiovascular1110%
Dermatological (non-injection-site)99%
General / Systemic (non-local)99%
Allergic / Anaphylactic88%
Musculoskeletal55%
Psychiatric / Neuropsychiatric44%
Respiratory22%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas3
New York2
California2
West Virginia1
Michigan1
Georgia1
South Carolina1
North Carolina1
Iowa1
Virginia1
Pennsylvania1
Florida1

Reports by month received

2019-041
2019-052
2019-062
2019-075
2019-081
2019-101
2019-1112
2020-011
2020-031
2021-051
2021-071
2021-081
2022-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.